07:12 AM EST, 11/03/2025 (MT Newswires) -- BioNTech (BNTX) reported a Q3 loss Monday of 0.12 euro ($0.14) per diluted share, swinging from earnings of 0.81 euro a year earlier.

Analysts polled by FactSet expected a loss of 0.95 euro.

Revenue for the quarter ended Sept. 30 was 1.52 billion euros, compared with 1.24 billion euros a year earlier.

Analysts surveyed by FactSet expected 719 million euros.

For 2025, the company said it now expects revenue of between 2.60 billion euros and 2.80 billion euros, compared with its prior outlook range of 1.70 billion euros to 2.20 billion euros. Analysts polled by FactSet expect 2.17 billion euros.

BioNTech shares were up 1.1% in recent premarket activity.